These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7692532)

  • 21. Modulation of kainic acid-induced activity in the mouse spinal cord by the amino terminus of substance P: sensitivity to opioid antagonists.
    Larson AA; Sun X
    J Pharmacol Exp Ther; 1993 Apr; 265(1):159-65. PubMed ID: 7682611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinal antinociceptive action of loperamide is mediated by opioid receptors in the formalin test in rats.
    Ray SB; Yaksh TL
    Neurosci Lett; 2008 Dec; 448(3):260-2. PubMed ID: 18973791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dynorphin: analgesic effect via kappa receptors in spinal cord of the spinal cords of rats].
    Xie GX; Han JS
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):231-4. PubMed ID: 6152645
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of N-methyl-D-aspartate antagonists and spantide on spinal reflexes and responses to substance P and capsaicin in isolated spinal cord preparations from mouse and rat.
    Brugger F; Evans RH; Hawkins NS
    Neuroscience; 1990; 36(3):611-22. PubMed ID: 1700328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of reciprocity between opioid and 5-HT3 receptors for antinociception in rat spinal cord.
    Yoon MH; Bae HB; Choi JI; Kim SJ; Chung ST; Kim CM
    Pharmacology; 2006; 77(4):195-202. PubMed ID: 16874010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
    Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F
    Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visceral antinociception produced by bee venom stimulation of the Zhongwan acupuncture point in mice: role of alpha(2) adrenoceptors.
    Kwon YB; Kang MS; Han HJ; Beitz AJ; Lee JH
    Neurosci Lett; 2001 Aug; 308(2):133-7. PubMed ID: 11457577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal substance P depresses the tail-flick response - antagonism by naloxone.
    Doi T; Jurna I
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):135-9. PubMed ID: 6170895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-Arg1, D-Trp7,9, Leu11-substance P (spantide) does not antagonize substance P-induced hyperexcitability of the nociceptive flexion withdrawal reflex in the rat.
    Wiesenfeld-Hallin Z; Duranti R
    Acta Physiol Scand; 1987 Jan; 129(1):55-9. PubMed ID: 2436439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the hyperalgesic effect induced by intrathecal injection of substance P.
    Matsumura H; Sakurada T; Hara A; Sakurada S; Kisara K
    Neuropharmacology; 1985 May; 24(5):421-6. PubMed ID: 2410805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CY 208-243: a unique combination of atypical opioid antinociception and D1 dopaminomimetic properties.
    Foote RW; Büscher HH; Römer D; Maurer R; Enz A; Gähwiler BH; Shearman GT; Seiler MP; Wüthrich H
    Life Sci; 1988; 42(2):137-52. PubMed ID: 2826954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
    Suh HW; Chung KM; Kim YH; Huh SO; Song DK
    Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delta-opioid receptor binding sites in rodent spinal cord.
    Traynor JR; Hunter JC; Rodriguez RE; Hill RG; Hughes J
    Br J Pharmacol; 1990 Jun; 100(2):319-23. PubMed ID: 2165837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The changing nature of pain control. Clinical aspects of endorphins and enkephalins.
    Hirst M
    J Can Dent Assoc; 1985 Jul; 51(7):493-8. PubMed ID: 2862981
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective opioid agonist and antagonist competition for [3H]-naloxone binding in amphibian spinal cord.
    Newman LC; Wallace DR; Stevens CW
    Brain Res; 2000 Nov; 884(1--2):184-91. PubMed ID: 11082500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat.
    Guo TZ; Poree L; Golden W; Stein J; Fujinaga M; Maze M
    Anesthesiology; 1996 Oct; 85(4):846-52. PubMed ID: 8873555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction of eptazocine, a novel analgesic, with opioid receptors.
    Nabeshima T; Matsuno K; Kamei H; Kameyama T
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):173-81. PubMed ID: 2992058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinociceptive and substance P antagonistic effects of intrathecally injected spantide II in rat: no signs of motor impairment or neurotoxicity.
    Wiesenfeld-Hallin Z; Xu XJ; Kristensson K; Håkanson R; Feng DM; Folkers K
    Regul Pept; 1990 Jun; 29(1):1-11. PubMed ID: 1697080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo tonic inhibition of spinal substance P (-like material) release by endogenous opioid(s) acting at delta receptors.
    Collin E; Mauborgne A; Bourgoin S; Chantrel D; Hamon M; Cesselin F
    Neuroscience; 1991; 44(3):725-31. PubMed ID: 1721687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.